
|Articles|March 22, 2022
Emerging Trends and Opportunities in Orally Inhaled Drug Products
Author(s)Catalent
There continues to be a rapid expansion in the orally inhaled therapeutic pipeline, underpinned by scientific, technological, manufacturing and regulatory advances across drug products and devices. In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
CPHI Milan Names 2026 Pharma Awards Finalists
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
5
